Page last updated: 2024-09-03

mosapride and levodopa

mosapride has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(mosapride)
Trials
(mosapride)
Recent Studies (post-2010)
(mosapride)
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
2869014217,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomymosapride (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asai, H; Hirano, M; Kameyama, M; Kubori, T; Minami, T; Nishinaka, K; Oda, M; Udaka, F; Ueno, S1

Trials

1 trial(s) available for mosapride and levodopa

ArticleYear
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.
    Parkinsonism & related disorders, 2005, Volume: 11, Issue:8

    Topics: Aged; Antiparkinson Agents; Benzamides; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Levodopa; Morpholines; Parkinson Disease; Positron-Emission Tomography; Receptors, Serotonin, 5-HT4; Serotonin Receptor Agonists; Stomach

2005
chemdatabank.com